Increased resistance of LFA-1-deficient mice to lipopolysaccharide-induced shock/liver injury in the presence of TNF-alpha and IL-12 is mediated by IL-10: a novel role for LFA-1 in the regulation of the proinflammatory and anti-inflammatory cytokine balance

J Immunol. 2003 Jul 15;171(2):584-93. doi: 10.4049/jimmunol.171.2.584.

Abstract

Challenge with low doses of LPS together with D-galactosamine causes severe liver injury, resulting in lethal shock (low dose LPS-induced shock). We examined the role of LFA-1 in low dose LPS-induced shock. LFA-1(-/-) mice were more resistant to low dose LPS-induced shock/liver injury than their heterozygous littermates, although serum levels of TNF-alpha and IL-12 were higher in these mice. C57BL/6 mice were not rescued from lethal effects of LPS by depletion of NK1(+) cells, granulocytes, or macrophages, and susceptibility of NKT cell-deficient mice was comparable to that of controls. High numbers of platelets were detected in the liver of LFA-1(+/-) mice after low dose LPS challenge, whereas liver accumulation of platelets was only marginal in LFA-1(-/-) mice. Following low dose LPS challenge, serum levels of IL-10 were higher in LFA-1(-/-) mice than in LFA-1(+/-) mice, and susceptibility to low dose LPS-induced shock as well as platelet accumulation in the liver of LFA-1(-/-) mice were markedly increased by IL-10 neutralization. Serum levels of IL-10 in LFA-1(+/-) mice were only marginally affected by macrophage depletion. However, in LFA-1(-/-) mice macrophage depletion markedly reduced serum levels of IL-10, and as a corollary, susceptibility of LFA-1(-/-) mice to low dose LPS-induced shock was markedly elevated despite the fact that TNF-alpha levels were also diminished. We conclude that LFA-1 participates in LPS-induced lethal shock/liver injury by regulating IL-10 secretion from macrophages and that IL-10 plays a decisive role in resistance to shock/liver injury. Our data point to a novel role of LFA-1 in control of the proinflammatory/anti-inflammatory cytokine network.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Clodronic Acid / administration & dosage
  • Cytokines / biosynthesis
  • Cytokines / metabolism*
  • Dose-Response Relationship, Immunologic
  • Down-Regulation / genetics
  • Down-Regulation / immunology
  • Female
  • Granulocytes / immunology
  • Granulocytes / metabolism
  • Immunity, Innate / genetics
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / metabolism*
  • Injections, Intravenous
  • Interleukin-10 / blood
  • Interleukin-10 / immunology
  • Interleukin-10 / metabolism
  • Interleukin-10 / physiology*
  • Interleukin-12 / blood
  • Interleukin-12 / physiology*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Leukocytosis / genetics
  • Leukocytosis / immunology
  • Leukocytosis / pathology
  • Lipopolysaccharides / administration & dosage*
  • Liver / immunology
  • Liver / metabolism
  • Liver / pathology*
  • Lymphocyte Function-Associated Antigen-1 / genetics*
  • Lymphocyte Function-Associated Antigen-1 / physiology
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Platelet Count
  • Receptors, Antigen, T-Cell, alpha-beta / biosynthesis
  • Shock, Septic / genetics
  • Shock, Septic / immunology*
  • Shock, Septic / mortality
  • Shock, Septic / pathology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / physiology*
  • Up-Regulation / genetics
  • Up-Regulation / immunology

Substances

  • Antibodies, Monoclonal
  • Cytokines
  • Inflammation Mediators
  • Lipopolysaccharides
  • Lymphocyte Function-Associated Antigen-1
  • Receptors, Antigen, T-Cell, alpha-beta
  • Tumor Necrosis Factor-alpha
  • Clodronic Acid
  • Interleukin-10
  • Interleukin-12